Get started
Author

Hideyuki Takedani

Self‐monitoring has potential for home exercise programmes in patients with haemophilia
2014 · M. Goto, H. Takedani, et al. · Haemophilia · 56
Strategies to encourage physical activity in patients with hemophilia to improve quality of life
2016 · Miwa Goto, Hideyuki Takedani, et al. · Journal of Blood Medicine · 40
PDF
Ten‐year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan
2014 · H. Takedani, M. Shima, et al. · Haemophilia · 30
PDF
A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics
2013 · A. Shirahata, K. Fukutake, et al. · Haemophilia · 30
A phase III clinical trial of a mixture agent of plasma‐derived factor VII a and factor X ( MC 710) in haemophilia patients with inhibitors
2016 · Y. Shinkoda, A. Shirahata, et al. · Haemophilia · 29
The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs
2022 · Yuji Kashiwakura, Nemekhbayar Baatartsogt, et al. · Molecular Therapy — Methods & Clinical Development · 26
Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII
2019 · Susan Kearney, Leslie J Raffini, et al. · Patient Preference and Adherence · 25
PDF
First report on the safety and efficacy of an extended half‐life glyco PEG ylated recombinant FVIII for major surgery in severe haemophilia A
2017 · K. Hampton, P. Chowdary, et al. · Haemophilia · 25
Results of clot waveform analysis and thrombin generation test for a plasma‐derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors—phase I trial: 2nd report
2012 · A. Shirahata, K. Fukutake, et al. · Haemophilia · 25
Clinical pharmacological study of a plasma‐derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors – Phase I trial
2011 · A. SHIRAHATA, K. FUKUTAKE, et al. · Haemophilia · 22
Joint Function and Arthropathy Severity in Patients with Hemophilia
2015 · Miwa GOTO, Hideyuki TAKEDANI, et al. · Journal of the Japanese Physical Therapy Association · 21
PDF
Continuous infusion during total joint arthroplasty in Japanese haemophilia A patients: comparison study among two recombinants and one plasma‐derived factor VIII
2010 · H. TAKEDANI · Haemophilia · 21
Deep venous thrombosis was not detected after total knee arthroplasty in Japanese patients with haemophilia
2015 · H. Takedani, K. Ohnuma, et al. · Haemophilia · 20
The risk of elective orthopaedic surgery for haemophilia patients: Japanese single-centre experience
2013 · J. Hirose, H. Takedani, et al. · Haemophilia · 17
Artificial intelligence–assisted ultrasound imaging in hemophilia: research, development, and evaluation of hemarthrosis and synovitis detection
2024 · Azusa Nagao, Yusuke Inagaki, et al. · Research and Practice in Thrombosis and Haemostasis · 15
Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa
2009 · H. TAKEDANI, H. KAWAHARA, et al. · Haemophilia · 15
Risk of deep venous thrombosis after total knee arthroplasty in patients with haemophilia A
2020 · Kumiko Ono, Hideyuki Takedani · Haemophilia · 14
Physical activity and its related factors in Japanese people with haemophilia
2019 · Miwa Goto, Nobuhiko Haga, et al. · Haemophilia · 14
Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia
2019 · Azusa Nagao, Nobuaki Suzuki, et al. · Haemophilia · 13
Inter‐observer reliability of three different radiographic scores for adult haemophilia
2010 · H. TAKEDANI, T. FUJII, et al. · Haemophilia · 12
Risk factors for postoperative complications of orthopedic surgery in patients with hemophilia: Second report
2018 · Jun Hirose, Hideyuki Takedani, et al. · Journal of Orthopaedics · 11
PDF
Clinical conditions and risk factors for inhibitor‐development in patients with haemophilia: A decade‐long prospective cohort study in Japan, J‐HIS2 (Japan Hemophilia Inhibitor Study 2)
2022 · Keiji Nogami, Masashi Taki, et al. · Haemophilia · 10
Excision of pseudotumour in a patient with haemophilia A and inhibitor managed with recombinant factor VIIa
2004 · H. Takedani, S. Mikami, et al. · Haemophilia · 10
Extension contracture stiff knee in haemophilia: Surgical timing and procedure for total knee arthroplasty
2022 · Kumiko Ono, Jun Hirose, et al. · Modern Rheumatology · 9
AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab – protocol for a multicentre, open-label, phase IV clinical study
2022 · Midori Shima, Hideyuki Takedani, et al. · BMJ Open · 8
PDF
Works count: 86
Citation count: 649
H-index: 15
I10-index: 23
Year
Topic
Type